☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Ultromics
Ultromics Enters into a Collaboration Agreement with Pfizer to Enhance the Development of EchoGo for the Detection of Cardiac Amyl...
January 11, 2024
Ultromics’ EchoGo Amyloidosis Receives the US FDA’s Breakthrough Device Designation to Detect Cardiac Amyloidosis
April 27, 2023
Load more...
Back to Home
Modal title
×
Modal body text goes here.